Striatal proenkephalin gene induction: Coordinated regulation by cyclic AMP and calcium pathways

Molecular Brain Research

Volumn 115, Issue 2, 2003, Pages 157-161

  Konradi, Christine ^a,b   Macías, Wendy ^a   Dudman, Joshua T ^a   Carlson, Richard R ^a  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Ca2+ calmodulin kinase; Depolarization; Enkephalin; L type Ca2+ channels; Protein kinase A; Striatum

Indexed keywords

4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; NIFEDIPINE; PROENKEPHALIN; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL MEMBRANE DEPOLARIZATION; CHANNEL GATING; CONTROLLED STUDY; CORPUS STRIATUM; GENE CONTROL; GENE INDUCTION; INHIBITION KINETICS; NEUROMODULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; RAT STRAIN;

EID: 0038784466     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00204-3     Document Type: Article

References (25)

1. Brotchie J.M., Henry B., Hille C.J., Crossman A.R. Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease. Adv. Neurol. 78:1998;41-52.
2. Bünemann M., Gerhardstein B.L., Gao T., Hosey M.M. Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the beta(2) subunit. J. Biol. Chem. 274:1999;33851-33854.
3. Calon F., Di Paolo T. Levodopa response motor complications: GABA receptors and preproenkephalin expression in human brain. Parkinsonism Relat. Disord. 8:2002;449-454.
4. Comb M., Birnberg N.C., Seasholtz A., Herbert E., Goodman H.M. A cyclic AMP- and phorbol ester-inducible DNA element. Nature. 323:1986;353-356.
5. Comb M., Hyman S.E., Kobierski L., Chu H.M., Van Nguyen T. Mechanisms underlying synaptic regulation of proenkephalin transcription. NIDA Res. Monogr. 111:1991;149-170.
6. Comb M., Mermod N., Hyman S.E., Pearlberg J., Ross M.E., Goodman H.M. Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. EMBO J. 7:1988;3793-3805.
7. Drolet G., Dumont E.C., Gosselin I., Kinkead R., Laforest S., Trottier J.F. Role of endogenous opioid system in the regulation of the stress response. Prog. Neuropsychopharmacol. Biol. Psychiatry. 25:2001;729-741.
8. Fabbri A., Jannini E.A., Gnessi L., Ulisse S., Moretti C., Isidori A. Neuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sites. J. Steroid Biochem. 32:1989;145-150.
9. 2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron. 19:1997;185-196.
10. Gerfen C.R., Young W.S. III. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
11. Hayward M.D., Pintar J.E., Low M.J. Selective reward deficit in mice lacking beta-endorphin and enkephalin. J. Neurosci. 22:2002;8251-8258.
12. Hong J.S., Yang H.Y., Gillin J.C., Di Giulio A.M., Fratta W., Costa E. Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum. Brain Res. 160:1979;192-195.
13. Iversen L.L., Lee C.M., Gilbert R.F., Hunt S., Emson P.C. Regulation of neuropeptide release. Proc. R. Soc. Lond. B. 210:1980;91-111.
14. Konradi C., Cole R.L., Green D., Senatus P., Leveque J.C., Pollack A., Grossbard S.J., Hyman S.E. Analysis of the proenkephalin second messenger-inducible enhancer in rat striatal cultures. J. Neurochem. 65:1995;1007-1015.
15. Konradi C., Kobierski L.A., Nguyen T.V., Heckers S., Hyman S.E. The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc. Natl. Acad. Sci. USA. 90:1993;7005-7009.
16. Konradi C., Leveque J.C., Hyman S.E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16:1996;4231-4239.
17. Kowalski C., Giraud P. Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures. Neuroscience. 53:1993;665-672.
18. Leveque J.-C., Macías W., Rajadhyaksha A., Carlson R.R., Barczak A., Kang S., Li X.-M., Coyle J.T., Huganir R.L., Heckers S., Konradi C. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J. Neurosci. 20:2000;4011-4020.
19. McBride W.J., Murphy J.M., Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101:1999;129-152.
20. Pollack A.E., Wooten G.F. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors. Mol. Brain Res. 12:1992;111-119.
21. Przewlocki R., Przewlocka B. Opioids in chronic pain. Eur. J. Pharmacol. 429:2001;79-91.
22. Raynor K., Kong H., Law S., Heerding J., Tallent M., Livingston F., Hines J., Reisine T. Molecular biology of opioid receptors. NIDA Res. Monogr. 161:1996;83-103.
23. Salzet M., Vieau D., Day R. Crosstalk between nervous and immune systems through the animal kingdom: focus on opioids. Trends Neurosci. 23:2000;550-555.
24. Steiner H., Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123:1998;60-76.
25. Xia Z., Dudek H., Miranti C.K., Greenberg M.E. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 16:1996;5425-5436.